During the past decade, Baptist Clinical Research Institute conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baptist Clinical Research Institute" #1 sponsor was "Veru Inc." with 2 trials, followed by "AVM Biotechnology Inc" with 1 trials sponsored, "Abbott" with 1 trials sponsored, "American Society of Clinical Oncology" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist Clinical Research Institute" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medpace, Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Baptist Clinical Research Institute" are "Congestive Heart Failure" (2 trials), "Metastatic Breast Cancer" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Acute Myocardial Infarction" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "Baptist Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Baptist Clinical Research Institute" are "Drug" (11 trials), "Biological" (2 trials), "Combination Product" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "AVM0703" (1 trials), "D-ribose" (1 trials), "Docetaxel" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Clinical Research Institute" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Baptist Clinical Research Institute". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Baptist Clinical Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Clinical Research Institute, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".